Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -386,000 | -324,000 | -384,000 | -4,000 | 69,000 |
| Depreciation Amortization | 351,000 | 268,000 | 186,000 | 91,000 | 360,000 |
| Income taxes - deferred | 64,000 | 68,000 | 84,000 | -15,000 | -31,000 |
| Accounts receivable | 106,000 | -163,000 | -174,000 | -111,000 | -139,000 |
| Accounts payable and accrued liabilities | -165,000 | -79,000 | -87,000 | -105,000 | 4,000 |
| Other Working Capital | 178,000 | 86,000 | 83,000 | -263,000 | -1,022,000 |
| Other Operating Activity | 116,000 | 271,000 | 273,000 | 295,000 | 126,000 |
| Operating Cash Flow | $264,000 | $127,000 | $-19,000 | $-112,000 | $-633,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -213,000 | -161,000 | -126,000 | -84,000 | -360,000 |
| Net Acquisitions | 7,000 | N/A | N/A | N/A | 3,000 |
| Other Investing Activity | 0 | -2,000 | -2,000 | -2,000 | 4,000 |
| Investing Cash Flow | $-206,000 | $-163,000 | $-128,000 | $-86,000 | $-353,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 828,000 | 159,000 | 142,000 | 27,000 | 699,000 |
| Debt Repayment | -889,000 | -201,000 | -171,000 | -46,000 | -604,000 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 9,000 |
| Dividend Paid | -78,000 | -63,000 | -50,000 | -37,000 | -148,000 |
| Other Financing Activity | 13,000 | 16,000 | -5,000 | -1,000 | 8,000 |
| Financing Cash Flow | $-126,000 | $-89,000 | $-84,000 | $-57,000 | $-36,000 |
| Exchange Rate Effect | 29,000 | 27,000 | 21,000 | 6,000 | -22,000 |
| Beginning Cash Position | 763,000 | 763,000 | 763,000 | 763,000 | 1,807,000 |
| End Cash Position | 724,000 | 665,000 | 553,000 | 514,000 | 763,000 |
| Net Cash Flow | $-39,000 | $-98,000 | $-210,000 | $-249,000 | $-1,044,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 264,000 | 127,000 | -19,000 | -112,000 | -633,000 |
| Capital Expenditure | -213,000 | -168,000 | -127,000 | -84,000 | -360,000 |
| Free Cash Flow | 51,000 | -41,000 | -146,000 | -196,000 | -993,000 |